U.S. Senate Committee on the Judiciary
- Judge Matthew Kacsmaryk is overseeing a lawsuit that challenges the FDA approval of mifepristone.
- A ruling could have nationwide implications for the drug's availability.
- A hearing was scheduled for Wednesday, but the judge hoped to delay publicizing the date, per WaPo.
A hearing for a lawsuit that could have significant outcomes for a government-approved abortion pill, mifepristone, has been scheduled for Wednesday.